Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tin H. Dang"'
Autor:
Steven J. Atlas, Anna N. A. Tosteson, Timothy E. Burdick, Adam Wright, Erica S. Breslau, Tin H. Dang, Amy J. Wint, Rebecca E. Smith, Kimberly A. Harris, Li Zhou, Jennifer S. Haas
Publikováno v:
JAMA network open. 5(9)
ImportanceHealth care systems focus on delivering routine cancer screening to eligible individuals, yet little is known about the perceptions of primary care practitioners (PCPs) about barriers to timely follow-up of abnormal results.ObjectiveTo desc
Autor:
Courtney J, Diamond, John, Laurentiev, Jie, Yang, Amy, Wint, Kimberly A, Harris, Tin H, Dang, Amrita, Mecker, Emily B, Carpenter, Anna N, Tosteson, Adam, Wright, Jennifer S, Haas, Steven J, Atlas, Li, Zhou
Publikováno v:
Studies in health technology and informatics. 290
Cancer screening and timely follow-up of abnormal results can reduce mortality. One barrier to follow-up is the failure to identify abnormal results. While EHRs have coded results for certain tests, cancer screening results are often stored in free-t
Autor:
Courtney J. Diamond, John Laurentiev, Jie Yang, Amy Wint, Kimberly A. Harris, Tin H. Dang, Amrita Mecker, Emily B. Carpenter, Anna N. Tosteson, Adam Wright, Jennifer S. Haas, Steven J. Atlas, Li Zhou
Cancer screening and timely follow-up of abnormal results can reduce mortality. One barrier to follow-up is the failure to identify abnormal results. While EHRs have coded results for certain tests, cancer screening results are often stored in free-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f457d33e4d943f8c6994d58e4e3c5c51
https://doi.org/10.3233/shti220112
https://doi.org/10.3233/shti220112
Autor:
Kimberly A. Harris, E. John Orav, Shoshana J. Hort, Li Zhou, Amrita Mecker, Anna N.A. Tosteson, Adam Wright, Amy J. Wint, Emily Carpenter, Molly L. Housman, Frank Y. Chang, David G. Aman, Tin H. Dang, Erica S. Breslau, Timothy E. Burdick, Rebecca Smith, Jennifer S. Haas, Steven J. Atlas, Jie Yang, Sanja Percac-Lima, Sarah Feldman, Constance D. Lehman, Courtney J. Diamond
Publikováno v:
Contemp Clin Trials
Introduction While substantial attention is focused on the delivery of routine preventive cancer screening, less attention has been paid to systematically ensuring that there is timely follow-up of abnormal screening test results. Barriers to complet